News PCL, Inc.

Stocks

A241820

KR7241820000

Biotechnology & Medical Research

End-of-day quote Korea S.E. 21/03/2025			5-day change	1st Jan Change
6,040.00 ^KRW	-1.63%		-.--%	-

30/12/24	Yeom Ju-hwan agreed to acquire 36.90% stake in mCureX Therapeutics, Inc. from PCL, Inc. for KRW 13.0 billion.	CI
30/08/24	PCL, Inc. announced that it has received KRW 4.004999835 billion in funding	CI

All News

Mentions Relevance

30/12/24	Yeom Ju-hwan agreed to acquire 36.90% stake in mCureX Therapeutics, Inc. from PCL, Inc. for KRW 13.0 billion.	CI
30/08/24	PCL, Inc. announced that it has received KRW 4.004999835 billion in funding	CI
22/08/24	PCL, Inc. announced that it expects to receive KRW 4.004999835 billion in funding	CI
25/06/24	PCL, Inc. announced that it has received KRW 9.99999838 billion in funding from JS & Partners Co., Ltd.	CI
21/06/24	Tiger Company Ltd. announced that it has received KRW 8.3 billion in funding from PCL, Inc.	CI
16/01/24	PCL, Inc. announced that it has received KRW 9.99999885 billion in funding from Global Emerging Markets	CI
26/12/23	PCL, Inc. announced that it has received KRW 9.99999838 billion in funding from Global Emerging Markets	CI
21/12/23	PCL, Inc. announced that it expects to receive KRW 9.99999885 billion in funding from Global Emerging Markets	CI
15/12/23	PCL, Inc. announced that it expects to receive KRW 9.99999838 billion in funding from JS & Partners Co., Ltd.	CI
31/05/23	PCL to Raise 36 Billion Won via Share Issuance	MT
23/03/23	PCL, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	CI
29/12/22	PCL, Inc. announced that it has received KRW 2.999990812 billion in funding from Hyeopsim Co ., Ltd.	CI
22/12/22	PCL to Raise 3 Billion Won via Share Issuance; Shares Jump 4%	MT
21/12/22	PCL, Inc. announced that it expects to receive KRW 2.999990812 billion in funding from Hyeopsim Co ., Ltd.	CI
12/12/22	PCL, Inc. announced that it has received KRW 12.060247575 billion in funding	CI
11/11/22	OliX Pharmaceuticals, Inc agreed to acquire 6.63% stake in PCL, Inc. for KRW8.04 billion.	CI
07/04/22	PCL, Inc.(KOSDAQ:A241820) dropped from S&P Global BMI Index	CI
20/09/21	PCL, Inc.(KOSDAQ:A241820) added to S&P Global BMI Index	CI
23/06/21	MCureX Therapeutics, Inc. announced that it expects to receive KRW 2 billion in funding from OliX Pharmaceuticals,Inc, PCL, Inc., Samyang Holdings Corporation	CI
25/03/21	PCL, Inc. announced that it has received KRW 40.499938368 billion in funding from a group of investors	CI
23/03/21	Datametrex AI Limited Secures Authorization by Health Canada for PCL Inc.'s COVID19 Rapid Antigen Test Kit	CI
18/03/21	PCL, Inc. announced that it expects to receive KRW 40.499938368 billion in funding from a group of investors	CI
01/09/20	Datametrex AI Limited Announces Submission of a Medical Devices Interim Order Request Form to Approve PCL, Inc.’s COV05 COVID19 Rapid Antigen Detection Kits to Health Canada	CI
12/08/20	Datametrex AI Limited Secures Rights to Sell and Distribute Pcl, Inc.’s COV05 COVID19 Rapid Antigen Detection Kits	CI
31/10/19	PCL, Inc. announced that it has received KRW 9.999993558 billion in funding from Korea Investment Partners Co. Ltd.	CI